DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments
International Immunopharmacology · 2024-08 · 137 · 112503
DOI: 10.1016/j.intimp.2024.112503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Ali S Alfardan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: DNA Methylation, Psoriasis, Decitabine, DNA (Cytosine-5-)-Methyltransferase 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: King Saud University.
Abstract (Originalsprache)
Psoriasis is classified as an autoimmune disorder characterized by abnormal immune response leading to the development of chronic dermal inflammation. Most individuals have a genetic vulnerability that may be further influenced by epigenetic changes occurring due to multiple variables such as pollutant exposure. Epigenetic modifications such as DNA methylation possess a dynamic nature, enabling cellular differentiation and adaptation by controlling gene expression. Di(2-ethylhexyl) phthalate (DEHP) and psoriatic inflammation are known to cause modification of DNA methylation via DNA methyltransferase (DNMT). However, it is not known whether DEHP, a ubiquitous plasticizer affects psoriatic inflammation via DNMT modulation. Therefore, this study investigated the effect of DNMT inhibitor, 5-aza-2'-deoxycytidine (AZA) on DEHP-induced changes in the expression of DNMT1, global DNA methylation, and anti-/inflammatory parameters (p-STAT3, IL-17A, IL-6, iNOS, IL-10, Foxp3, Nrf2, HO-1) in the skin and the peripheral adaptive/ myeloid immune cells (CD4+ T cells/CD11b+ cells) in imiquimod (IMQ) model of psoriasiform inflammation. Further, psoriasis-associated clinical/histopathological features (ear thickness, ear weight, ear PASI score, MPO activity, and H&E staining of the ear and the back skin) were also analyzed in IMQ model. Our data show that IMQ-treated mice with DEHP exposure had increased DNMT1 expression and DNA methylation which was associated with elevated inflammatory (p-STAT3, IL-17A, IL-6, iNOS) and downregulated anti-inflammatory mediators (IL-10, Foxp3, Nrf2, HO-1) in the peripheral immune cells (CD4+ T cells/CD11b+ cells) and the skin as compared to IMQ-treated mice. Treatment with DNMT1 inhibitor caused reduction in inflammatory and elevation in anti-inflammatory parameters with significant improvement in clinical/histopathological symptoms in both IMQ-treated and DEHP-exposed IMQ-treated mice. In conclusion, our study shows strong evidence indicating that DNMT1 plays an important role in DEHP-induced exacerbation of psoriasiform inflammation in mice through hypermethylation of DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Electronic address: anadeem@ksu.edu.sa.
- Industrial Engineering Department, College of Engineering, King Saud University, Riyadh 11421, Saudi Arabia.
- Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Förderung
- King Saud University
Zitieren
APA
Alfardan, A. S., Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Alqinyah, M., Attia, S. M., El-Sherbeeny, A. M., Al-Harbi, M. M., Al-Shabanah, O. A., Ibrahim, K. E., Alhazzani, K., & Alanazi, A. Z. (2024). DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments. International Immunopharmacology, 137, 112503. https://doi.org/10.1016/j.intimp.2024.112503
Vancouver
Alfardan AS, Nadeem A, Ahmad SF, Al-Harbi NO, Alqinyah M, Attia SM, et al. DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments. International Immunopharmacology. 2024;137:112503. doi:10.1016/j.intimp.2024.112503
BibTeX
@article{Alfardan2024,
author = {Alfardan, Ali S and Nadeem, Ahmed and Ahmad, Sheikh F and Al-Harbi, Naif O and Alqinyah, Mohammad and Attia, Sabry M and El-Sherbeeny, Ahmed M and Al-Harbi, Mohammad M and Al-Shabanah, Othman A and Ibrahim, Khalid E and Alhazzani, Khalid and Alanazi, Ahmed Z},
title = {DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments},
journal = {International Immunopharmacology},
year = {2024},
volume = {137},
pages = {112503},
doi = {10.1016/j.intimp.2024.112503}
}
EUVIMED